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Abstract
DNP FINAL REPORT: BREAKING THE CYCLE:
CARE COORDINATION INTERVENTIONS AND SICKLE CELL READMISSIONS
NAPH’TALI B. EDGE
DNP Project Team Chair: Dr. Kathleen Helgesen, DNP, APRN, CPNP-PC
The University of Texas at Tyler
May 2021
Background
Approximately 100,000 people in the United States are affected by Sickle Cell Disease (SCD).
Sickle Cell Disease represents the second highest readmitting diagnosis at Houston Methodist
Hospital. The purpose of this study is to determine the impact of implementing care coordination
interventions to reduce hospital readmissions of patients with SCD.
PICOT
In adult patients with SCD in the acute care hospital setting, how does care coordination
intervention compared to no care coordination intervention affect the readmission rate for
patients with SCD over a 3 – 6-month period?
Body of Evidence
Eleven studies were critical appraised and included in the body of evidence: One Randomized
Control Trial, seven Cohort Studies, and three Quality Improvement Projects. Four evidencebased interventions were found to reduce readmissions for SCD patients.
Implementation
Two interventions were implemented: Disease-specific discharge education and scheduling
post-discharge follow-up appointments prior to discharge. These interventions were conducted
by bedside nurses, case managers, and SCD champions over six-months.
Outcomes/Evaluation
The 30-day readmission rate for SCD was reduced by 22%. There was also a 0.9-day reduction
in length of stay and a 17% reduction in Emergency, Observation, and Inpatient encounters.
Impact
This project found that implementing evidence-based care coordination interventions can reduce
the 30-day readmission rate for patients with SCD.
Sustainability

x

Effective care coordination is a key aspect to mitigation of hospital readmissions. Establishing
processes to incorporate these strategies into the daily work of care coordinators may serve as the
springboard for additional EBP interventions and further support continued quality improvement.

xi

Chapter One: Development of the Leadership Question and Problem Identification
Introduction
Approximately 100,000 people in the United States (U.S.) are affected by sickle cell
disease (SCD) (Bulgin et al., 2018). One out of every 365 African Americans and one out of
every 16,300 Hispanic-Americans are diagnosed with the disease at birth (Centers for Disease
Control and Prevention, 2019). The state of Texas is the third leading state in SCD incidence
with one in every 500 African Americans and one in every 3,600 Hispanic-Americans affected
(Yates, 2014). This accounts for 23% of the total population of patients with SCD in the US
(Sickle Cell Association of Houston, 2018). Patients with SCD are hospitalized approximately
eight times per year (Sickle Cell Association of Houston, 2018). The average cost per admission
is $27,700 and the average cost of healthcare expenditures over the lifespan is $7.7 million.
(Sickle Cell Association of Houston). Re-hospitalization rates for SCD range from 30-47% and
22.1% for 30 days and 14 days, respectively (Leschke et al., 2011).
External Evidence
People living with SCD face significant morbidity and early mortality (Wilkie et al.,
2010). From 1975-2005, the mean age of death for people with SCD was 33.4 years for males
and 36.6 years for females. The mortality rate for adults increased by one percent each year
during the same period (Lanzkron & Haywood, 2015). Following the FDA approval of
hydroxyurea, the life expectancy for patients with homozygous SCD increased to 42 years for
males and 48 years for females (Okam et al., 2014). This demonstrates that patients with SCD
die three to four decades sooner than patients without SCD (Sickle Cell Association of Houston,
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2018; Statista, 2019; Tewari et al., 2015). Approximately 10% of children with SCD will have a
symptomatic stroke, which can cause learning problems and lifelong disabilities (American
Society of Hematology, 2016). In some African countries, nearly all babies born with SCD die in
early childhood (Wilkes et al., 2010).
Sickle cell disease is characterized by chronic hemolytic anemia, increased susceptibility
to infections, end organ damage, and intermittent episodes of vascular occlusion that result in
acute and chronic pain (Centers for Disease Control and Prevention, 2019). Inadequate pain
management decreases quality of life and patient satisfaction and increases hospital length of
stay and 30-day readmission rates (Ballas & Lusardi, 2005; Ezenwa et al., 2016; Treadwell et al.,
2016). Brodsky et al. (2017) ascertained that the cost of care in the U.S. exceeded $1.1 billion,
predominantly from hospitalizations,. Cline et al. (2018) found that the 30-day readmission rate
for SCD approached 32% in 2010. Treadwell et al. (2016) discovered that in patients with SCD,
complications and health care costs significantly increased after age 16.
The transition from childhood to adulthood is a high-risk period for youth with SCD due
to the complexities of a disease where multiple comorbidities develop in childhood and progress
in adulthood (Blinder et al., 2013; Treadwell, 2018; Dickerson et al., 2012). Disease
complications may be exacerbated during this period secondary to poor continuity and resulting
in increased morbidity and mortality after age 18 years. In a large cohort study in Texas, of 940
children who were followed from birth, seven deaths occurred between age 18 and 20 (Quinn et
al., 2010). The transition period is also a contributor to increased stress and frustration for
patients with SCD and providers (Stollon et al., 2015).
Many patients with SCD also struggle with psychosocial and economic barriers. These
patients are generally of low socioeconomic status, have low health-related quality of life
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(HRQL) (Panepinto et al., 2007), and lack resources to adequately maintain self-care (Jenerette
et al., 2015). Patients with SCD also are typically challenged by numerous social determinants of
health (SDOH) and may suffer from a concomitant psychiatric illness (Adam et al., 2017). They
frequently have poor social support and lack trust with a healthcare provider, thus contributing to
strained relationships (Weisberg et al., 2013). Healthcare disparities greatly impact patients with
SCD as barriers to access to care, inadequate training and treatment, and lack of funding for
research to improve treatment continue to exist (American Society of Hematology, 2016). Lack
of education, negative provider attitudes towards patients with SCD, and poor provider
knowledge about SCD worsens pain management (Haywood et al., 2009).
Internal Evidence
At Houston Methodist Hospital (HMH), SCD is the one of the highest readmitting
diagnoses with >46% of patients readmitted within 30-days of discharge (Vizient, 2018). It is
estimated that 20 – 30% of these readmissions were preventable. Between June 2017 and
December 2018, there were 391 inpatient encounters for SCD, where 13 patients accounted for
30% of the encounters and 322 emergency room (ED) encounters for SCD where eight patients
accounted for 60% of the visits (Epic ED Universe, 2018). The average length of stay (ALOS)
for patients with SCD was seven days compared to an expected length of stay (LOS) of four days
(Vizient, 2018). The cost of care per visit averaged around $20,000. The Hospital Consumer
Assessment of Healthcare Providers and Systems (HCAHPS) scores for patients with SCD on
communication with nurses, pain management, care transitions, and discharge information
measures were in the 25th percentile (Hospital Consumer Assessment of Healthcare Providers
and Systems, 2018).
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The average age of patients with SCD that presented to Houston Methodist Hospital
between June 2017 and December 2018 was 26 years. Forty percent of these patients had
moderate to high severity of illness (SOI) and risk or mortality (ROM) based on clinical
documentation (Claro Healthcare, 2018). Seventy-five percent had a high probably of
readmission secondary to eight or more SDOH. Some of these included problems related to:
Education and literacy, employment or unemployment, physical or social environment, housing,
and certain economic or psychosocial circumstances. The combination of physiological and
psychological issues predisposes patients with SCD to frequent and prolonged hospitalizations
and high risk for early death. These factors influence the probability of patients falling through
the cracks and landing in hospital emergency rooms where approximately 40% of visits result in
inpatient admission (Lanzkron & Haywood, 2015).
Development of the Clinical/Leadership Question and Problem
The number of risk factors and SDOH were of great concern to the executive team.
Combined with high readmission rates and length of stay for patients with SCD, the readmission
reduction task force at HMH agreed that this issue required immediate action. To identify
literature to address these concerns, the following PICOT question was asked: In adult patients
with SCD in the acute care hospital setting, how does care coordination intervention compared
to no care coordination intervention affect the readmission rate for patients with SCD over a 36 month period?
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Chapter 2: Evidence Synthesis and Models
Systematic Search for Evidence Process and Results
A systematic search of three electronic databases was conducted to identify studies to
assist with decision-making. The Cumulative Index of Nursing and Allied Health Literature
([CINAHL]; Appendix A), PubMed (Appendix B), and the Cochrane Database of Systematic
Reviews ([CDSR]; Appendix C)) were the databases searched. A foreground question was
formatted to drive the search, and keywords, inclusion criteria, use of subject headings or
controlled vocabulary, and combining and limiting searches were all strategies used to find the
best evidence to help answer the PICOT question.
The keywords search included the following terms: anemia, sickle cell, disease, sickle
cell, SCD, sickle, care coordination, case manage*, social work, coordination of care, continuity
of care, readmi*, 30-day readmi*, and readmission (see Appendices A, B, and C). To ensure
consistency with the systematic search, the same search terms and order of search was conducted
across all databases. Additionally, advanced searching was conducted to support finding the best
relevant evidence and, for databases with controlled vocabulary or indexing functionality, those
terms were also explored. Furthermore, other types of applications were assessed some of which
included a search for multiple types of clinical evidence, clinical practice guidelines, article
synopsis, and bibliographic databases.
Inclusion criteria and limits were used to narrow the results. The criteria comprised the
following: human, English language, abstract available, peer reviewed, and inpatients.
Randomized control trials (RCTs) and meta-analyses were included in the limit settings initially
as a means of identifying the strongest evidence to support clinical decision-making.
Subsequently, these limits were removed to ascertain other evidence that would be beneficial to
5

answer the foreground question. Boolean connectors and truncation were utilized to streamline
the search.
Subject headings were incorporated into the search strategy to identify pertinent articles.
Within CINAHL, the “explode” and major concept features were utilized to ensure all the
specific terms were included under the general headings. Combined with the Boolean feature,
variations of sickle cell anemia or sickle cell disease and case manage, social work, care
coordination, and continuity of care produced a range of three to 62 hits. Adding a truncation of
readmission resulted in a range of one to three hits. After further review, the total yield from
CINAHL was three articles.
Within the PubMed database, the Medical Subject Heading (MeSH) feature was utilized
broaden the search to avoid having to consider every synonym (Melnyk & Fineout-Overholt,
2015). The explode subject heading was utilized to narrow the search. These strategies,
combined with the Boolean connector feature, produced a range of eight to 197 abstracts or
articles. Combining a truncation of readmission produced a range of zero to nine hits. After
further review, the total yield from PubMed was two articles. Within CDSR, the MeSH feature
was also utilized. Additional use of the Boolean connector produced one hit. Combining a
truncation of readmission produced zero hits. Total yield from CDSR was zero articles.
Five articles provided relevant information to help answer the PICOT question. To
identify additional studies, the find similar results feature in CINAHL and similar articles
feature in PubMed was also used. This led to an additional three articles. Google was searched
for other articles of interest and grey literature, and the ancestry method, along with hand
searching, was conducted. Six additional articles were ascertained utilizing these processes,
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yielding a total of 11 articles retained for critical appraisal: One RCT, seven cohort studies, and
three quality improvement projects (QIPs).
Critical Appraisal
A general appraisal overview (GAO) was conducted for each study to determine the
purpose or aim, design, and sampling specifics. A rapid critical appraisal (RCA) was conducted
for each study to appraise the evidence and to determine whether the literature identified in the
search was relevant, valid, reliable, and applicable to the clinical question (Melnyk et al., 2010).
The RCA helps to distinguish the best evidence from unreliable evidence and unbiased evidence
from biased evidence (Melynk & Fineout-Overholt, 2015). In appraising the literature, articles
were evaluated considering the level of evidence and the degree to which each answered the
clinical question (Melnyk et al., 2010).
When conducting the RCA, the framework was reviewed to assess the clinical question,
variables, and study design to determine generalizability. Although systematic reviews and RCTs
represent higher levels of evidence, only one article in the upper echelon of the rating hierarchy
was found. Validity, reliability, and applicability were high for the RCT and moderate for the
cohort studies for the quality improvement studies. Several of the articles included studies or
projects implemented in the pediatric or combination of pediatric and adult inpatient and/or
outpatient settings. Considering the onset and chronicity of SCD and the importance of care
coordination across the continuum, these articles were retained as they contained information
relevant to the clinical question. Also, many of the articles conducted studies longer than the 3–
6-month timeframe referenced in the PICOT question. These articles were also retained. Thus,
all 11 articles that underwent RCA were retained as keeper studies.
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Evaluation
An evaluation table was created to organize, compare, and describe agreement amongst
the findings of the 11 keeper studies (See Appendix D). Levels of evidence ranged from level II,
well-designed RCTs, to Level VI, QIPs. The studies were a broad collection published between
2012 and 2018. Evaluation of the studies found similarities with types of study and interventions.
Statistically significant readmission reduction was noted in many of the studies. Differences
include age, setting, process measures, and data analysis. Despite the differences, the evidence
supported implementing care coordination interventions to reduce readmissions.
An assessment of the principles of ethics was completed. The review of the principles of
ethics assisted with providing confidence that the proposed interventions could be implemented
in a manner that protects patient confidentiality and ensures patient safety. Five principles of
ethics were considered in the review: beneficence, non-maleficence, autonomy, justice, and
fidelity. No ethical issues were noted (see Appendix E). The Houston Methodist Research
Institute (HMRI) also conducted a review of the project. The HMRI determined there was no
need for to obtain Institutional Review Board (IRB) approval (see Appendix F). The
organization supported proceeding with project implementation.
Synthesis
Four synthesis tables were developed to clarify similarities and differences across studies:
Levels and types of evidence; interventions; outcomes; and studies with similar findings (See
Appendices G, H, I, and J). Appendix G highlighted that most of the evidence was from cohort
studies, with quality improvement projects most common. Appendix H revealed common
interventions were: Disease-specific discharge education, care planning during the inpatient
admission, scheduling of post-discharge follow-up appointments prior to discharge, post8

discharge follow-up calls, home visits, and follow-up / post-discharge care in an outpatient
infusion center. Appendix I demonstrated that discharge education, scheduling follow-up
appointments prior to hospital discharge, and outpatient follow-up (i.e., in a sickle cell infusion
center) interventions were the most effective in reducing 30-day hospital readmissions, the
primary outcome of interest. Furthermore, scheduling of post-discharge follow-up appointments
prior to discharge appeared to be the most effective intervention with the broadest impact.
Finally, Appendix J showed that care coordination strategies, specifically, the inpatient, diseasespecific, discharge planning education and scheduling follow-up appointments prior to patient
discharge have significant impact on reducing 30-day hospital readmission rates and mild impact
on reducing hospital length of stay.
Recommendations
Based on the body of evidence, the recommendation is implementation of diseasespecific discharge teaching on patient self-management and arrangement of post-discharge
follow-up appointments with a Primary Care Provider (PCP) or Hematologist prior to patient
discharge. Additionally, evidence suggests that conducting post-discharge calls and home visits,
in combination with discharge education and scheduling post-discharge follow-up appointments
prior to hospital discharge, may further reduce hospital readmissions. The expected outcome is a
conservative 20% reduction in 30-day hospital readmissions for patients with SCD.
EBP Model
The EBP Model used to assess care coordination interventions and the impact on 30-day
hospital readmissions of patient with SCD is The Johns Hopkins Nursing Evidence-based
Practice (JHNEBP) Model. This model was chosen because of its strategic framework and focus

9

on guiding nurses and ancillary staff in translating the best evidence into practice. The goal of
this model is to transform the culture of nursing to an evidence-based focus in a way that is
simple, functional, and applicable. The model is a mentored linear process that begins with a
clinical inquiry question and initiates a Practice Question, Evidence, and Translation (PET
process) (Dang & Dearholt, 2017). The PET process provides a systematic approach for the
inter-professional team to refine the question, seek out the best evidence, and translate evidence
into practice.
Change Model
The ADKAR change model was chosen to support change management throughout
project implementation. The ADKAR change management model is a tool for planning change
management activities. The ADKAR methodology outlines five milestones in successful
change: Awareness, desire, knowledge, ability, and reinforcement (Prosci, 2018). Awareness
encompasses explaining the rationale for the change. It creates the space to explain the why and
allows for open communication and shared understanding. Desire empowers and engages
individuals through regular communication and collaboration. Knowledge helps with
identification of training needs including social learning. This allows for reflection and sharing
of experiences and ensures the necessary structure and tools are in place to implement new ideas.
Ability focuses on assessment of how to accomplish tasks. It also provides a safe space for
inquiry of participant’s vulnerabilities and fears, barrier identification, and prioritization of tasks.
Reinforcement includes establishing a mechanism for sustaining the change (von Matern, 2020).
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Leadership Model
Leadership is an important aspect of actualizing the DNP role. Transformational
leadership is a leadership approach that causes a change in individuals and social systems with a
potential result that followers will become the leaders (Kendrick, 2011). Transformational
leadership involves four factors: idealized influence, inspirational motivation, intellectual
stimulation, and individual consideration (see Figure 1). Individually, these factors can provide
forward movement, and cumulatively deliver performance that far exceeds previous norms
(Kendrick, 2011).
The transformation leadership model was instrumental throughout implementation of the
project. It served to enhance the motivation, morale, commitment, and performance of the team.
The team established a shared vision in the early stage of project implementation including
setting ground rules and individual and team expectations. Expectations encompassed elements
of transformational leadership including: Leading by example and role-modeling expected
behaviors; encouraging and rewarding creativity and innovation (thinking outside of the box);
demonstration of grace and tolerance; and exhibiting compassion and support.
Figure 1: Transformation Leadership Model
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Chapter 3: Project Design and Methodology
Setting and Population
The setting for conducting the interventions took place at the flagship hospital of Houston
Methodist. Houston Methodist Hospital is a not-for-profit, faith-based, 907-bed hospital located
in the Texas Medical Center that provides highly specialized health services to the community
and the world (Houston Methodist, 2019). The population of focus was adult patients (>/=18
years of age) diagnosed with SCD admitted as inpatient to HMH during the timeframe of August
2019 – January 2020. Ninety-nine percent of this population was African American with the
average age being 26 years old (Epic ED Universe, 2018; Vizient, 2018). The number of patients
admitted with SCD was fifty-seven patients. Seventy percent of the patients were </= 29 years of
age. Approximately 60% of those </= 29 years were between the ages of 21-29 years old.
Approximately 90% of these patients were </= 39 years.
Table 1
Patient Demographics
Age
18 – 20
21 – 29
30 – 39
40 – 49
50 – 59
>60

Number of patients
6
34
11
4
2
0

Seventy-five percent of these patients had a primary payer source of Managed Medicaid
(Epic ED Universe, 2018). Seventy-five percent of the patients were considered high risk for
readmission based on risk factors and SDOH. Forty percent had a moderate to severe severity of
12

illness and risk for mortality index (Claro Health, 2018). Seventy-two percent of the population
completed high school, yet only 5% of the population had college degrees.
Patients that presented to HMH’s Emergency Department (ED) for care were registered
by the admissions clerk and triaged by an ED nurse. At triage, an ED Provider screened patients
and initiated a treatment plan. Patients deemed appropriate for discharge from the ED received
discharge instructions on an After-Visit Summary (AVS), which included recommendations for
follow-up and prescriptions. If the ED Provider determined that admission was necessary, she/he
contacted a Hospitalist to admit the patient. The Hospitalist entered the admission orders and
nursing and the interdisciplinary team (IDT) initiated the plan of care.
An EPIC report was created and distributed daily. This report included any patient newly
admitted with a primary diagnosis of SCD. The report was distributed to the Unit case manager
or social worker for communication and collaboration with the attending physician and the
interdisciplinary team. During interdisciplinary rounds, the team discussed the goals of care and
anticipated discharge date with the patient. The primary nurse or case manager conducted patient
education utilizing materials from the SCD Toolkit (see Appendix K) and documented education
in the patient’s medical record. The case manager or social worker discussed an ideal date and
time for post-discharge appointments and scheduled the appointments based on the patient’s
preference. When patients were medically ready for discharge, the Attending Physician entered
the discharge order and instructions for post-discharge care on the AVS. The discharging nurse
completed the treatment plan and provided the patient with the AVS and prescriptions.
Timeline Including Gantt Chart
A timeline for the EBP project was created to establish clear direction and priorities. The
timeline served as a guide to demonstrate the chronological sequence of actions for the project
13

along with specific time intervals. A Gantt Chart was also completed. The Gantt Chart served
as a visual depiction of project tasks and milestones. It was also used to improve
communication, efficiency, and effectiveness. The Gantt Chart allowed for greater specificity of
the project scope and provided a better lens into past, present, and future project activity (See
Appendix L).
Logic Model
A Logic Model was completed to assist with project planning and implementation. The
Logic model provide a visual illustration of project resources, activities, and expected outcomes.
Inputs included human and organizational resources and supply needs. Outputs included
educational and training activities to support project implementation and sustainability. Shortterm, midterm and long-term goals were established, and an assessment of assumptions and
external factors was completed (see Appendix M).
Implementation of evidence-based practice may be fraught with barriers and challenges
that impede or hinder progress and outcomes. Lack of resources such as IT support, time
restrictions, heavy workload, and organizational constraints are also potential barriers to EBP
implementation (Fischer et al., 2016). The success of EBP implementation hinges upon several
factors. Incorporating interventions into the normal workflow of staff and simplifying processes
will help mitigate barriers and challenges. To minimize or reduce barriers, a barriers action plan
was implemented (see Appendix N).
Utilization of the EBP Model
The JHNEBP served as the framework to provide the interdisciplinary team with a visual
depiction of the EBP process ensuring bidirectional practice and learning and continuous quality
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improvement. The JHNEBP framework supported the interprofessional team throughout the
steps of the EPB process to ensure: (a) the process was structured and systematic; (b) appropriate
identification and implementation of EBP interventions that answered the clinical question; (c)
adherence to the project timeline, goals, and objectives; (d) increased probability for successful
patient outcomes and patient, physician, and staff engagement and satisfaction; (e) decreased risk
of error; and (f) minimized opportunities for scrutiny or criticism. The EBP Model demonstrated
the integration between the EBP Process and the JHNEBP model. The multi-linear approach
supported implementation of the interventions in a simple format and strengthened buy-in,
sustainability, and success. It also yielded operational and practice improvements that led to
additional inquiry and discovery (see Appendix O).
Utilization of Change Model
The ADKAR change model was utilized to support organizational change and project
implementation. The initial focus was helping stakeholders and the project team understand the
need for change. This included assessment of the size and scope of the change, completion of the
OSRSIEP, and providing the structure and strategy for change. We then moved to development
of our roadmap, and communication, training, and coaching plans. To reinforce change, we
worked with key stakeholders to collect and analyze feedback, diagnose gaps, identify and
manage resistance, and develop corrective action plans. Finally, we implemented reward and
recognition activities to celebrate success and reinforce positive behavior (see Appendix P). The
ADKAR change model provided a strong framework for expectations and accountability.
Stakeholder familiarity with the model made implementation easier and helped boost team
competence and confidence.
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Final Budget
Estimated expenses for this project were approximately $42,000. This included costs for
salaries, supplies, marketing/communication, training, and other expenses. The salary line item
included cost of time for the Nurse Educators or Case Managers to conduct training sessions and
for the nurses, Case Managers, Social Workers, and Community Health Workers to conduct the
interventions. The supplies line item included costs for material needed to successfully
implement the interventions. This included paper, ink, binders, and dividers. The
marketing/communication line item included costs for hospital branded personal health records
for distribution to each patient; and the other line item includes costs for CHW mileage
reimbursement (see Appendix Q).
The return on investment (ROI) was determined by assessing the reduction in
unnecessary readmissions as cost avoidance. A 20% reduction in avoidable readmissions was
anticipated. The pre-intervention total number of readmissions was 95. The anticipated number
of readmissions post-intervention was </=75. The anticipated return on investment expressed as
cost avoidance was as follows:

Pre-implementation readmissions cost

$20,000 cost/readmission X 95

= $1.9M

Post-implementation readmissions cost

$20,000 cost/readmission X 75

= $1.5M

$1.9M - $1.5M

=

$400K savings

$400,000 - $42,000 implementation costs

=

$358,000 ROI.

This figure represents the annualized ROI for the one-year period after project implementation.
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Data Collection and Analysis Plan
Data management needs included information on compliance with process measures and
the resulting impact on the outcomes measure. Process measures included:
1. Percentage completion of at least one SCD-specific educational session divided by the
total number of educational opportunities
2. Percentage of post-discharge appointments scheduled prior to discharge divided by the
total number SCD discharges.
3. Percentage of weekly post-discharge phone calls divided by the total number of expected
calls per patient.
4. Percentage of post-discharge home visit completed divided by the total number of
expected home visits.
These process measures were chosen as a means of assessing and tracking compliance
with the four evidence-based interventions originally planned for implementation. SCD-specific
discharge education and scheduling of post-discharge follow-up appointments were
implemented, and process measure data was collected. Bi-weekly reports were supplied by the
quality analytics team. Data were based on documentation in the electronic medical record.
Indications that the project was progressing well included feedback from the project team and
consistent documentation completion of interventions.
The 30-day hospital readmission rate for patients with SCD was the outcome measure.
This measure was chosen because it is a high-impact metric that reflects the quality of care and
services provided. The Centers for Medicare and Medicaid Services’ (CMS) readmission data
typically runs a few months in arrears; thus, concurrent data was tracked using the hospital’s
patient documentation platform and the Vizient database. There were challenges with matching
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our internal data with the CMS readmission methodology. Internal data only included
readmission back to the Houston Methodist system and CMS data included readmission to any
hospital.
Readmission data included inpatient to inpatient admissions within 30 days of the index
admission (discharged in inpatient status and readmitted in inpatient status) for any diagnosis.
Patients returning to the hospital within 30 days of discharge in observation status were not be
counted as a readmission. The data analysis plan included an analysis of historical data compared
to post-implementation data. Discrete data was collected and aggregated and the 5 Whys was
utilized to determine causes for readmissions.
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Chapter 4: Project Implementation, Outcomes, Impact, and Results
Process Indicators/Milestones
Process measure data components included interventions completed compared to the total
number of opportunities. Data were measured and reported as a percentage. The threshold or
minimum completion was set at 90%. Target and stretch goals were set at 95% and 100%,
respectively.
Project Results, Barriers, and Solutions
The original intent was implementation of four interventions over a three-month
timeframe. A late fall, early winter implementation was planned as this timeframe correlated
with higher readmissions for this population. The Senior Leadership Team expressed concerns
about the timeline and requested initiating the project earlier. They recommended
implementation in late summer or early fall in anticipation of the influenza season and to prevent
high SCD readmissions historically seen during cooler months. There was also anecdotal
information from providers that follow-up compliance for patients with SCD decreased during
cooler temperatures further supporting the need to initiate the project sooner. The compromise
was to implement two of the four evidence-based interventions over a six-month period. Thus,
sickle cell disease-specific education and scheduling of post-discharge follow-up appointments
prior to discharge were implemented between August 2019 through January 2020.
Implementation of post-discharge follow-up calls and Community Health Worker (CHW)
home visits were planned for April 2020 – June 2020. Unfortunately, the COVID-19 pandemic
halted implementation. The world, including the U.S. and the state of Texas, was severely
impacted by the pandemic. The Houston metropolitan area was significantly affected. Houston
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Methodist Hospital closed approximately half of the units and shifted many medical patients to
other hospitals in the system. This included patients with SCD. Additionally, several of the
hospital staff were furloughed, some for several months during the height of the pandemic. This
included case management and social work staff. Case managers and social workers that were
not furloughed covered multiple units. They also shifted their workflow from in-person to
telephonic coordination to avoid exposure, risk of spread, and retain vital PPE for roles required
for patient facing.
In-person office visits shifted to virtual visits making coordination of care for patients
with SCD more challenging. Furthermore, visitation for post-acute care and other partners was
prohibited; thus, in-person hand off to the SCAH could not happen. There was also trepidation
regarding home visits from patients, family members, and the SCAH. To date, COVID-19
continues to plague HMH. Implementation of the remaining two interventions continue to be on
hold. Though unable to implement all four of the evidence-based interventions, implementation
of SCD-specific discharge education and scheduling of post-discharge follow-up appointments
together had a significant impact on the SCD 30-day hospital readmission rate.
Data Collection and Analysis
Process measure compliance for SCD-specific educational sessions to patients was 100%.
There were 178 encounters and documentation of SCD-specific education prior to patient
discharge was present in the medical record of all encounters. Education was considered
complete if documented in any of the following areas: (a) nursing documentation in-progress
notes or flowsheets, (b) case manager or social worker documentation in-progress notes, or (c)
care coordination observation and documentation of education conducted by the SCAH staff.
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Process measure compliance for scheduling of post-discharge follow-up appointments
prior to discharge was 74%. Of the 178 encounters, documentation of post-discharge follow-up
appointments prior to discharge was present in the medical record in 132 encounters. There was
a total of 46 encounters where post-discharge follow-up appointments were not scheduled. Root
cause analysis audits found the following causes: (a) 17 encounters of patient refusal or requests
to self-schedule appointment, (b) 14 incomplete encounters, six unplanned discharges, (c) five
encounters of staff omission, and (d) four late appointments (scheduled after patient discharge)
(see Appendix R). An observation noted was case management and social work staff were more
engaged and more likely to ensure documentation of confirmed appointments in the patient’s
AVS when assisted or supported by the SCAH.
Outcomes Measures, Analysis, and Financial Impact
As a result of these interventions, total readmissions for this population were reduced by
22%. The estimated cost of care per readmission was $20,000; thus, cost savings or avoidance
totaled $620,000. Implementation costs were approximately $42,000; thus, the annualized ROI
was $578,000. This is $220,000 more savings than estimated (originated estimated savings were
$358,000). Also, average LOS was reduced by almost 1 day (7.7 down to 6.8) and Emergency
Department and Observation visits decreased by 18.7% and 23.5%, respectively (see Appendix
S). This ROI does not include revenue gained from length of stay (LOS) reduction or increased
capacity. Increase capacity for patients needing acute care with higher paying diagnostic related
groups (DRGs) was observed. Further analysis is needed to determine the overall ROI to include
the following: Reimbursement of other DRGs admitted minus that of SCD patients that would
have been admitted; LOS savings; and improved ED and observation throughput.
As a result of this project, the following new questions arose:
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•

What would the impact have been if all interventions were implemented?

•

What is the financial impact of the LOS reduction?

•

What was the financial impact (revenue obtained) from improving emergency room and
hospital capacity?

•

What are the risks associated with longer LOS for patients with SCD? Hospital acquired
conditions or infections? Overdose of patient medications? Increased mortality?

•

What impact did or could this project have on overall patient, employee, and physician
engagement and satisfaction?

•

How might this information change the perspective and practices of emergency
department, general/internal medicine (Hospitalists), Hematologists, and other providers?

•

Did staffing, skill mix, or employee knowledge deficits impact completion of
interventions (and thus process measures)?

•

How much of the outcomes were influenced by absence or presence of social support for
this group of patients?

•

Would the outcomes be different if the interventions were administered by only RNs or
Social Workers? Would having both involved further impact the outcomes?

•

Would the outcomes be better if all education were done by the SCAH?

•

Would consistent demonstration and documentation of teach-back impact outcomes?

•

What would the impact be if we were not dealing with a global pandemic?

•

Would outcomes be different or better if SCD patients were centralized on specific units?

•

What percentage of patients attended follow-up appointments as scheduled?

•

Were better outcomes achieved for those that attended follow-up appointment as
scheduled for those that did not attend follow-up appointments.
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Smith et al. (2019) found that implementation of a case management model and CHW
interventions reduced readmission rates by 17%, emergency department returns by 5%, SCD
patient days by 53%, and SCD care costs by 47%. McWilliams et al. (2019) used random
allocation to a Transition Services (TS) program that bridges inpatient, outpatient, and home
settings. The interventions provided patients virtual and in-person access to a dedicated
multidisciplinary team for 30-days versus usual care of discharge instructions. They noted a 7%
reduction in the readmission rate of those receiving transition services compared to those
receiving usual care. These studies provide additional insight into interventions that may
improve care transitions across the continuum and subsequently assist hospitals and healthcare
systems providing care to patients with SCD with achieving the Institute for Healthcare
Improvement’s quadruple aim.
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Chapter 5: Project Sustainability, Conclusions, and Recommendations
Implications of Project Results
Organizationally, there is great opportunity to implement similar measures across the
system as several of the Houston Methodist facilities provide care to patients with SCD.
However, given the effect of COVID-19, one cannot predict the impact that this pandemic will
have on the SCD population and the organization’s strategic plan. There has been discussion
about centralizing care of patients with SCD on specific units at HMH and at specific Houston
Methodist facilities; however, no decision has been made to date. Though policy revisions were
not made, case management and social work departmental procedure and practice changes were
implemented and standardized. Additionally, efforts are in progress to reengineer the current
patient education processes and platforms. The intent is to boost patient awareness and
understanding, enhance applicability and practicality of patient self-management and postdischarge care, and ultimately, improve patient outcomes and satisfaction. These efforts are not
specific to patients with SCD (though focus on this population may have served as a catalyst to
such efforts) but to all patients.
The implications of these results to the community have been noticeable. The SCAH and
the University of Texas Comprehensive Sickle Cell Center have been more involved and
collaborative. The SCAH provided some of the disease-specific discharge education and
conducted some post-discharge follow-up calls with certain high-risk patients. Though data was
not consistently collected and shared, this may have had an impact on the outcomes data. The
SCAH submitted proposals to embed community health CHWs in the Houston Methodist system
to support education efforts and to serve as a liaison to thwart unnecessary admissions. The goal
is for CHWs to connect ED and inpatients to community resources to provide ongoing support to
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mitigate SDOH. The CWHs can also assist with patient education, coordinate post-discharge
follow-up appointments, assist patients with completion of personal health records, and connect
patients to support groups to strengthen the community network.
The University of Texas Comprehensive Sickle Cell Center has participated in joint
operating committee meetings and are exploring ways to better serve patients that access care at
Houston Methodist facilities and at their Sickle Cell Center. Moreover, we have initiated
discussions with Texas Children’s Hospital regarding establishing a partnership. The goal is to
better bridge patients from pediatric environment to adulthood including navigation of the
complex adult healthcare system.
Additionally, State Representative Jarvis Johnson, and United States Congresswoman
Sheila Jackson-Lee have expressed and shown support of our efforts through the Sickle Cell
Association of Houston. Representative Johnson and Congresswoman Jackson-Lee expressed
interest in partnering on drafting and introducing bills to improve funding, access, and care
practices for patients with SCD. Patients with SCD have also expressed support and shown
excitement of such efforts via social media platforms.
Sustainability Plan
The Executive Vice-President and Chief Innovation Officer asked the Chief Nursing
Officer, Magnet Coordinator, and an Associate Chief Medical Officer (ACMO) to prioritize this
project to include resource support for spread. Furthermore, the ACMO participated in meetings
with the Chief Executive Officer of the SCAH, University of Texas Comprehensive Sickle Cell
Center leadership, and a state representative. The purpose of the meetings was to partner with
these agencies on development of a strategy to improve outcomes for patients with SCD.
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Although weekly distribution and review of process measure data was intended,
competing priorities and other obligations prevented this cadence. Instead, process measures data
was distributed bi-weekly. Leaders shared this data with their respective teams during huddles
and department meetings and requested feedback. Feedback included the need for earlier and
more frequent discharge education and identification and mitigation of social determinants of
health (SDOH). The team also suggested direct access to scheduling for case managers and
creation of a hard stop in the electronic medical record that requires schedulers to enter key
elements (date, time, location, and provider) in the appointment section of the patient after visit
summary. Some of this feedback was incorporated into the project design.
Case management and social work leaders, unit directors, quality leaders, and others
began planning implementation of the last two interventions and discussed a rollout plan for the
next Houston Methodist facility. Additionally, preliminary discussions regarding sharing and
distribution of findings at the local, state, and national level started. Unfortunately, the COVID19 pandemic halted further implementation and spread.
Key Lessons Learned
There were several key lessons learned. To successfully support comprehensive disease
management for patients with SCD, community partnership is essential. The SCAH played a
significant role in education and coordination of care both of which were vital to successful
patient outcomes. The SCAH’s extensive knowledge of SCD, personal experience of living with
SCD, and familiarity of caring for people with SCD helped to foster trust and inspire altruism.
The SCAH team helped engender a spirit of connectedness and heighten compassion exhibited
by the team. This action aligned well with Houston Methodist’s ICARE values of integrity,
compassion, accountability, respect, and excellence.
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During the implementation phase, we signed a Business Associate Agreement (BAA)
with the SCAH to support implementation of the four interventions. The BAA did not contain a
fee structure for reimbursement of services rendered. Thus, support provided by the SCAH
during this time was complimentary. The SCAH agreed to these terms as a good faith measure to
show its value and impact on sickle cell outcomes. Complementary support was not intended to
continue indefinitely; however, the terms of such support including the timeline were not
included in the signed BAA. A revised BAA, which included the fee structure for services, was
later submitted to the Houston Methodist Hospital Chief Financial Officer and the Director of
Community Benefits for review. Unfortunately, it was not approved. Though the results of the
project were positive, the inability to come to an agreement on reimbursement of services led to
a mutual decision by HMH and the SCAH to dissolve the BAA. A valuable lesson on contract
negotiation, fee structures, and reimbursement was learned.
Establishing a mechanism for direct and real-time communication with federallyqualified health centers, infusion centers, and other care sites would be helpful. This would aid
timely scheduling of follow-up appointments, ideally within one week of discharge. Establishing
a process for automatic social work consults based on provider and nursing assessment and
identification of social determinations of health may also be useful. Reengineering the
flowsheets for documentation of patient teaching is another key lesson for improvement. It is
suggested that HMH refine the flowsheets to support ease of use and incorporate teach-back.
Another lesson learned was the importance of assessing patient education platforms to
ensure they are patient-centered. Consideration of reading and comprehension levels and
incorporation of adult learning strategies are critical. Leveraging smart phones, interactive
gaming, social media forums, and other types of technology is critical in connecting with young
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adults including those with SCD. Collaborating with marketing to refine patient education
materials in a more user-friendly and readable format would have been ideal. Creation and
utilization of pain passports to guide providers on individualized pain management plans are also
important. Providing care coordination staff with direct access to schedule post-discharge followup appointments with PCPs or Hematologists would also be ideal.
Additionally, social media and other forms of information technology have also begun to
influence the culture of patients and families of patients with SCD. Parents of patients with SCD
often use social media to learn more about their child’s disease, to seek and develop a support
system, and to share concerns or experiences (Vaughn et al., 2011). Young adults often rely on
social media and other forms of information technology to self-treat symptoms, help with
isolation and stigma, and to communicate information via message boards, direct messaging, etc.
to help make decisions about care (Henriques, 2017). Using social media to understand the
culture and connect with patients and incorporating it into the plan of care may also help ensure
project success.
It is important to discuss the impact culture had on this project. African Americans,
especially those diagnosed with SCD, generally mistrust the healthcare system. Murray (2015)
noted that mistrust in the healthcare system permeates the African American culture and stems
from generations of enslavement, discrimination, and abuse. For patients with SCD, perception
of healthcare provider judgment, generalization, stereotyping, and accusation contribute to
patient mistrust and subsequent health disparities (Singh et al., 2016). The resulting fear from
these negative experiences have contributed to a reluctance to trust healthcare providers which
ultimately impacts overall health outcomes and leads to a widening of healthcare disparities
(Murray).

28

Cultural and medical mistrust and racial identity encompass attitudinal variables that
have been shown to affect satisfaction with care in African Americans and inhibit Caucasian
American providers from establishing care relationships (Benkert et al., 2009). Furthermore,
provider biases and negative attitudes (Singh et al., 2016) complicate and strain relationships.
Mistrust is sometimes precipitated by an action or lack of action. In healthcare, this may have
severe implications and contribute to misperceptions, decreased patient compliance, lower
patient satisfaction, lack of quality care, and poor outcomes (Benkert et al., 2009).
Developing trust is a skill and an art. It requires creating a space where patients feel safe,
supported, valued, and heard. This space should be devoid of judgment, free of shame, and
absent of guilt. This is particularly true for patients with SCD as mistrust is high, and satisfaction
is low. To build trust, patients with SCD must believe that nurses are trustworthy. Patients must
feel confident that they will be respected and accepted for who they are and what they believe.
Dignity and compassion must be maintained, and advocacy upheld. Consistency of displaying
integrity, honesty, and fidelity during nurse-patient interactions may positively contribute to
sustaining trust, reducing health disparities, and improving outcomes.
Incorporating self-assessment and diversity assessment tools into practice or scheduling
periodic diversity training for all providers and staff is worth consideration. Diversity and
inclusion training may improve the perception of patients with SCD. Recruiting and embedding
Sickle Cell Advocates or Champions throughout the hospital is recommended. Trust is
fundamental to the relationship between the patient to nurse, patient to provider, etc.; thus, HMH
should invest time, money, and resources to create a culture of trust and ensure that trust is
fundamental to everything that we do.
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Project Recommendations
Implementation of care coordination interventions to reduce the 30-day hospital
readmission rate for patients with SCD is strongly recommended. Great success was observed
by implementing two evidence-based care coordination interventions; thus, the recommendation
is implementation of at least two interventions to achieve success. Partnering with community
networks to establish a comprehensive plan is also advised. Assessment and mitigation of SDOH
would also be ideal. Community networks may have resources and other support necessary to
manage SDOH and reduce risk factors of patients with SCD. Comprehensive training on SCD
management is important. Collaborating with Hematologists and leveraging evidence-based
SCD toolkits should be part of a hospital’s SCD management protocol. Finally, awareness of
institutional and cultural bias, diversity and inclusion training, and recruitment of SCD
champions are highly recommended.
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Chapter 6: DNP Practice-Scholar Role Actualization
Role Impact
At Houston Methodist, leading medicine is not just a tagline, it is what the organization
strives to do. Leading medicine can only be achieved by commitment to implementation of
evidence-based practice and innovation from the providers, nurses, leaders, and all members of
the interdisciplinary team. The DNP Practice Scholar plays a pivotal role in cultivating a spirit of
inquiry and creating a culture of evidence-based practice. The DNP role is not as evolved and is
underutilized in current state. There is great opportunity to better leverage this role to transform
policies and standard operating procedures (SOPs) and lead quality improvement and evidencebased projects that ultimately enhance patient outcomes and satisfaction.
As a DNP Practice Scholar, my plan to diffuse EBP within the organization has begun by
educating leaders at all levels on EBP, the role of the DNP, and how DNP and PhD leaders can
collaborate to improve patient care. Education also included: Review of the EBP process; how
to conduct a systematic literature search; creation and utility of evidence and synthesis tables and
Gantt Charts; identification and implementation of evidence-based interventions; and review of
quality improvement tools including the PDSA cycle and quality charts. Education was an
important first step because it served as the catalyst to change. I also initiated discussions with
the Chief Nursing Officer and members of the Magnet Council on creating a culture of EBP,
hardwiring EBP Standard Operating Procedures (SOPs), and increasing EBP Champions
throughout the hospital.
My strategy to continue diffusing EBP within the organization consists of: (a) working
with executive leadership on promoting the DNP role, (b) hiring DNP leaders, (c) infusing EBP
in the physician credentialing process, (d) recruiting librarian support, (e) partnering with
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Magnet leadership and nursing quality on recruiting EBP Champions, (f) rewriting policies and
procedures to include EBP expectations. (g) expanding our EBP Council to include other
interprofessional roles, (h) partnering with Human Resources to refine role-based clinical ladders
to include EBP expectations, and (i) implementing a monthly DNP Support Group to support
DNPs throughout their journey at Houston Methodist. I would also like to work closely with
midlevel leaders on how to hardwire EBP processes in their service areas to improve patient
outcomes. In addition, partnering with our Patient & Family Experience team to ensure patient
advocates are involved in our EBP initiatives is of interest.
Houston Methodist Hospital is a Magnet-designated hospital. Nurses at Magnetdesignated hospitals have higher knowledge, stronger perceived EBP cultures, and greater EBP
mentoring than non-Magnet-designated nurses (Melnyk et al., 2010). EBP has been linked to
positive nursing and patient outcomes as nurses set the standards for excellence through
leadership, scientific discovery and dissemination, and implementation of new knowledge
(American Nurses Credentialing Center, 2020). The DNP educated nurse has unique skills. The
DNP can contribute to clinical practice, leadership, health policy, implementation and evaluation
of evidence-based research, and nursing education (Tenhunen et al., 2019).
Though a Magnet-designated hospital with organizational recognition of the role of EBP
in healthcare, leader awareness of EBP is variable, EBP competencies are inconsistently applied,
and cultural readiness for change is tenuous. In general, mid-level and executive leaders were
misinformed about the actual role of the DNP and its value. The weakness of this knowledge
deficit is that these leaders are unable to advocate or articulate the importance of the role and its
benefits to patients, staff, and the organization. Opportunities remain to continue education about
the DNP role, increase DNP executive presence, and improve DNP and PhD partnerships.
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Additional opportunities include demonstration of the value of the DNP, implementing a DNP
recruitment and retention strategy, and increasing organizational DNP utilization. These actions
may decrease the threats of poor patient outcomes, disinterest in DNP terminal degree
attainment, and increased turnover post-graduation secondary to lack of organizational support of
the DNP role.
My future goal as a DNP leader is to inspire and encourage a cadre of nurse scholars to
be change-makers in healthcare. I aspire to take a more active role in healthcare reform by
empowering and advocating for equitable access to quality care, affordable care, and a more
diverse and inclusive healthcare workforce especially at the executive level. I want to educate
policy-makers about SDOH. I would also like to reform broken and antiquated systems that
disenfranchise people of color and predispose minorities to poor quality of life and high
morbidity and mortality. I also want to serve as a mentor to healthcare leaders at all levels.
Finally, I hope to partner with high schools and community networks to educate African
American males on health promotion and disease prevention while simultaneously exposing and
inspiring them to enter the field of nursing.
Summary
The DNP program has been challenging and rewarding. The rigor of this program was
unlike any other I have undergone. This experience has ignited my passion, tested my patience,
and amplified my persistence. Throughout this journey, I have leveraged and leaned into my
strengths. In reviewing my top five Strengths Finders 2.0 Strengths, two of the top five strengths
fall into the Relationship Building domain (Includer and Positivity), two falls into the Influencing
domain (Winning Others Over—WOO and Communication), and one falls into the Executing
domain (Achiever) (Rath, 2007). None of my top five strengths are in the Strategic Thinking
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domain. I have learned that I am more people-focused and I thrive off interacting and
collaborating with others. Utilization of my top five strengths have helped me feel more engaged,
productive, and connected. I also feel less stressed and more confident. This journey has taught
me to pay more attention to other’s strengths as well and to proactively look for ways to improve
communication and collaboration.
This experience has also helped improve my emotional intelligence. Early in this journey,
I learned that my collective management in personal competence (self-awareness and selfmanagement) is strong. I was also strong in one aspect of social competence (social awareness);
however, there was opportunity to strengthen the other aspect of social competence (relationship
management) (Bradberry & Greaves, 2009). Though I could accurately pick up on the emotions
of others and sense what they were thinking and feeling, I was not as good at using my
awareness to manage interactions successfully. To build my relationship management and thus
improve my overall emotional intelligence, I made a conscious effort to explain my decisions,
address difficult situations timely and consistently, and to be more open and curious. I am now
aware of the need to be vulnerable and, when appropriate, share more of myself with others.
This journey has also strengthened my global understanding of leadership and the impact
that it has on individuals, groups, and the health care system. I have become a more wellrounded leader and have grown in two areas of leadership that I have struggled with in the past:
Organizational savviness and financial/business acumen. I am delighted to say that I have done
so while maintaining work-life balance and actively engaging in self-care. The difficult road to
obtain the DNP could not have been achieved without prayer, passion, and persistence. I am
proud of this accomplishment and very much looking forward to positively contributing to
nursing and healthcare as a DNP.
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Appendix G: Levels and Types of Evidence

Level of Evidence
1
2
3
4
5
6
7
8
9
10
11
Synthesis
Level 1: Systematic
0 of 11
Review or MetaAnalysis
Level II: Randomized X
1 of 11
Control Trials
Level III: Control
0 of 11
Trials without
Randomization
Level IV: Case Control
X
X
X
X
X
X
X
7 of 11
or Cohort Study
Level V: Systematic
0 of 11
Review of Qualitative
or Descriptive Study
Level VI: Qualitative
X
X
X
3 of 11
or descriptive study
(includes evidence
implementation
projects)
Level VII: Expert
0 of 11
Opinion or Consensus
1 = Bronstein, L.R., et al. (2015); 2 = Gao, W., et al. (2018); 3 = Dangi-Garimella, S. (2015); 4 = Limenis (2017); 5 = Harrison et al. (2014); 6 = Lanzkron, S.
et al. (2015); 7 = Koch, K. L., et al. (2013); 8 = Leschke, J., et al. (2012); 9 = Manwani, D., et al. (2014); 10 = Pashankar, F.D., et al. (2018); 11 = Onimoe,
G.I., et al. (2016).
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Appendix H: Synthesis Table: Interventions

Interventions

1

2

Home Visit
Post Discharge
Phone Calls
Discharge
instructions /
disease education
Inpatient Care
Planning
Schedule Followup visits before
discharge
Youth Adult
Transition Clinic

X
X

X
X

Self-management
strategies

X

3

4

5

6

7

8

9

10

11

2 of 11
3 of 11

X
X

X

X

X

X

X

X

4 of 11

1 of 11

X
X

Synthesis

X

X

7 of 11

X

1 of 11

X

1 of 11

Sickle Cell
2 of 11
X
X
Outpatient Infusion
Center / Clinic
Prescribe
2 of 11
X
X
Hydroxyurea
1 = Bronstein, L.R., et al. (2015); 2 = Gao, W., et al. (2018); 3 = Dangi-Garimella, S. (2015); 4 = Limenis (2017); 5 = Harrison et al. (2014); 6 = Lanzkron, S.
et al. (2015); 7 = Koch, K. L., et al. (2013); 8 = Leschke, J., et al. (2012); 9 = Manwani, D., et al. (2014); 10 = Pashankar, F.D., et al. (2018); 11 = Onimoe,
G.I., et al. (2016).
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Appendix I: Synthesis Table: Outcomes

Interventions

Outcomes
Self-Management
30-day Readmission
Rate
14-day Readmission
Rate
Patient satisfaction /
engagement
Health Literacy
Number of Infusion
Visits
ED visits
Admissions / Acute Care
Utilization

1

2

3

4

5

6

7

8

9

10

11

HV
PDCC

HV
DCE
FUA

DCE
FUA
YATC
SMS

FUA

PDCC

SCIC

SCIC

FUA

ICP
FUA

DCE
FUA
HYDR

DCE
FUA
HYDR

Synthesis

1 of 11
10 of 11

-

1 of 11
2 of 11
1 of 11
1 of 11
1 of 11
3 of 11

Length of Stay (LOS)
2 of 11
High Utilizers
1 of 11
1 = Bronstein, L.R., et al. (2015); 2 = Gao, W., et al. (2018); 3 = Dangi-Garimella, S. (2015); 4 = Limenis (2017); 5 = Harrison et al. (2014); 6 = Lanzkron, S. et al. (2015); 7 =
Koch, K. L., et al. (2013); 8 = Leschke, J., et al. (2012); 9 = Manwani, D., et al. (2014); 10 = Pashankar, F.D., et al. (2018); 11 = Onimoe, G.I., et al. (2016).
HV=Home Visits; PDCC=Post-discharge calls; DCE=Discharge Education; FUA=Follow-Up Appointments; YATC = Youth Adult Transition Center; SMS =self-management
system; SCIC = Sickle Cell Infusion Center; ICP = Inpatient Care Plan; HYDR = Hydroxyurea
= decrease
= increase - = no change
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Appendix J: Synthesis Table: Studies with Similar Findings

No.

Study
Author

Year

No. of
Participants

Mean Age

Study
Design

Intervention

Major finding that addresses PICOT

2

Gao, W., et
al.

2018

149,748

-

PCS

HV, DCE, and FUA reduce RR

3

DangiGarimella,
S.

2015
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16.3

PCS

HV
DCE
FUA
DCE
FUA
YATC
SMS

9

Manwani,
D., et al.
Pashankar,
F.D., et al.

2014

-

-

QIP

DCE, FUA, YATC, and SMS reduce RR.

ICP
ICP and FUA reduce LOS and RR.
FUA
10
2018
216
10.68
QIP
DCE
DCE, PDCC, FUA, HYDR reduce LOS, acute admissions, and
PDCC
RR.
FUA
HYDR
11
Onimoe,
2016
91
16.8
QIP
DCE
DCE, FUA, PDCC, and HYDR reduce RR.
G.I., et al.
FUA
PDCC
HYDR
CC=Care Coordination; DC=Discharge; DCE=Discharge Education; DCI=Discharge Instructions; FUA=Follow-up Appointments; HV = Home Visits; ICP =
Inpatient Care Plan; LOS = Length of Stay; MM=Medication Management; PCS=Prospective Cohort Study; QIP=Quality Improvement Project; PDCC=Postdischarge calls; Readmission Rates; SMS = Self-Management Strategies; - = unknown; YATC = Youth Adult Transition Center;
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Appendix K: SCD Toolkit

What to Know Before You Go to the ER
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Appendix K: SCD Toolkit continued
Medical Appointment Sheet
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Appendix K: SCD Toolkit continued
Medical Emergency Information Sheet
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Appendix K: SCD Toolkit continued
SMART Goals
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Appendix K: SCD Toolkit continued
Healthy Behavior Contract
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Appendix K: SCD Toolkit continued
Daily Pain Tracking Sheet
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Appendix K: SCD Toolkit continued
Describe the Pain Sheet
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Appendix K: SCD Toolkit continued
Patient Education Materials: Stress Diary Sheet
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Appendix K: SCD Toolkit continued
Water Intake Tracking Sheet
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Appendix K: SCD Toolkit continued
Questions to Ask My Health Provider
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Appendix K: SCD Toolkit continued
Fact Sheet: Sickle Cell Status
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Appendix K: SCD Toolkit continued
Fact Sheet: Sickle Cell Status
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Appendix K: SCD Toolkit continued
Sickle Cell Disease and Hemoglobin S
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Appendix K: SCD Toolkit continued
Sickle Cell Disease and Hemoglobin S
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Appendix L: Timeline with Gantt Chart
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Appendix L: Timeline with Gantt Chart continued
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Appendix L: Timeline with Gantt Chart continued
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Appendix L: Timeline with Gantt Chart continued
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Appendix L: Timeline with Gantt Chart continued
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Appendix M: Logic Model

Program Name and Student Name: UT Tyler DNP Program, Leadership Track
Naph’tali Edge

Program Goal: Reduce unnecessary, avoidable 30-day hospital readmissions of patients with a primary diagnosis of sickle cell
disease (SCD) by 20% over the course of 3 months.

Human Resources

Resources/Inputs
Necessities List
1. Nurse Educator
Provide 1 hour of training on SCD discharge
teaching to nursing staff. Estimated number
of staff requiring education will be 120 RNs.
This will include staff on all shifts (i.e. day,
night, and weekend). Estimated time
commitment needed for Nurse Educator will
be 15 hours pre-implementation. Post
implementation estimates include a total of 5
hours of Nurse Educator time for re-education
to staff. Estimate approximately 20% or 12
staff RNs may require re-education.
Anticipate re-training to occur in first month
of implementation.
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Wish List
1. Dedicated RN or discharge nurse for the sickle
cell population
2. Community Health Worker support to connect
with patients prior to discharge, participate in
education with RN, and continue education
post-discharge (including completion of a
personal health record.
3. Unit Secretary support to schedule all postdischarge follow-up appointments.

Appendix M: Logic Model continued
Provide 1-hour training on how to schedule
follow-up appointments to Care Coordination
staff. Estimated number of staff requiring
training will be 100. Anticipate one-time
training for each staff member with training to
occur pre-implementation. This will include
staff on day shift. Do not anticipate need for
Nurse Educator to re-educate staff on the
scheduling process.
Care Coordination post-discharge follow-up
calls. Estimated time for each call will be one
hour each week for a total of four weeks.
Community Health Worker post-discharge
home visits. Estimate two one-hour phone
calls within the 30 day timeframe.
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Appendix M: Logic Model Continued

Office Supplies

Organization Resources

1. Office paper and color ink cartridges
1. iPads to distribute to patients with SCD for
Anticipate needing approximately 25 reems of
alternative discharge teaching/learning (i.e.
paper and 10 color ink cartridges to provide
computer-based, video game, interactive,
discharge literature for approximately 150
etc.).
SCD inpatient encounters (60 for first month, 2. PHR costs absorbed by community partner
50 for second month, 40 for third month).
(Sickle Cell Association of Houston).
2. Discharge Binders
Anticipate needing 150 binders for discharge
education.
3. PHR
1. Dedicated call line for staff to call to schedule
post-discharge follow-up appointments.
2. Teach back module uploaded in Learning
Management System (LMS). This will be the
learning module utilized by the Nurse
Educator for training purposes. Will also use
to track compliance of teach back as a process
measure.
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1. Direct access to PCP and/or Hematology
provider schedules to enter appointments
directly 24/7 by all staff.

Appendix M: Logic Model continued
OUTPUTS
Activities
Audience(s)
1-hour training sessions on care of the
patient with SCD. Training to focus
on management of sickle cell disease
including self-management strategies,
red flags to watch for, medication
management, alternative health
strategies, community resources and
connections, follow-up care, etc.

Staff RNs.

Collaborative meetings with team
including outpatient team to discuss
care transitions and care coordination
across the continuum. Team building
activities will be included during
collaborative meetings.

1-hour training sessions on scheduling
follow-up appointments and
conducting post-discharge phone
calls. Training should include
collaboration with patients and
families to assess most date/time of
appointment most convenient to them
and assessing for and arranging
transportation (if needed).

Physicians, Staff
RNs, Case Managers,
Social Workers,
Schedulers,
Patient/Family and
Advisors, Outpatient
team, etc.

Short-Term

OUTCOMES
Mid-Term

Increased unit RN staff understanding of SCD
management and patient self-management education
as evidenced by improved post-test scores
(compared to pre-test scores) by the first 2 weeks of
project implementation.

Increased patient compliance of
self-management strategies as
evidenced by completion of
personal health record and
improved patient satisfaction on
discharge-related and transition of
care questions on patient
satisfaction survey within the first
90 days of project implementation.

Completion and distribution of employee profiles for
at least 90% of team members to encourage getting
to know each other at least 1 week prior to project
implementation.

Increased patient satisfaction with
staff communication and
collaboration as evidenced by
improvement in patient satisfaction
survey within the first 90 days of
project implementation.

Improvement of scheduling process as evidenced by
increased number of follow-up appointments
scheduled prior to patient discharge within 1 month
of project implementation.
Consistency in conducting weekly post-discharge
phone calls to support transitions of care.

Care Coordination
staff.
Stakeholders
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Improvement in scheduling process
as evidenced by increased number
and percentage of patients that
keep/attend follow-up appointments
within first 90 days of project
implementation.
Compliance with conducting
weekly calls as evidenced by
increased patient understanding of
self-management, red flags to
watch for, and transitions of care.

Long-Term
Increased staff satisfaction as
evidenced by improvement
employee engagement scores
within 1 year of project
implementation.

Increased staff satisfaction as
evidenced by improvement
employee engagement scores
within 1 year of project
implementation.

Increased engagement with
appointment availability via
patient satisfaction survey within 6
months to 1 year of project
implementation.

Appendix M: Logic Model continued
•
•
•
•
•
•
•
•

Patients/Family
Providers
Educators
Nurses
Case Managers
Social Workers
Schedulers
Community Partners

Process Indicators

1. Number of inpatients discharged with SCD diagnosis that receives pre-discharge disease-specific discharge teaching / total number of
patients discharged with SCD diagnosis X 100.
Goal: Threshold >/= 90% compliance
Target >/= 95% compliance
2. Number of inpatients discharged with SCD diagnosis with post-discharge follow-up appointment scheduled prior to discharge / total
number of patients discharged with SCD diagnosis X 100.
Goal: Threshold >/= 90% compliance
Target >/= 95% compliance
3. Number of weekly post-discharge phone calls divided by the total number of expected calls per patient (four calls per patient).
Goal: Threshold >/= 90% compliance
Target >/= 95% compliance

4. Number of post-discharge home visits completed divided by the total number of expected home visits
Goal: Threshold >/= 90% compliance

External Influencing Factors
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Target >/= 95% compliance

Appendix M: Logic Model continued
Environmental setting will be an inpatient acute care setting on the medical surgical units.
Environmental/Setting

Times
Audiences targeted

Influences/Programs

Outcome indicator will include:
• Readmission Rate
•

Goal is implementation in Fall/Winter months as evidence suggests that readmissions of patients
with SCD increase during this time. Plan to compare outcomes to previous Fall/Winter months.

Staff Nurses
Care Coordination staff
Schedulers
• Providers/Physicians
• Executive, Senior, and Mid-level leaders
• Sickle cell champions
• Patient/Family Advisors
• Sickle Cell Scholars and Practice Champions
• Sickle Cell Association of Houston
• UT Comprehensive Sickle Cell Center
•

Engagement of State Senators and US Representatives would be ideal.

Assumptions
•
•
•
•
•
•
•
•

Readmission Rate is too high and can be decreased.
Patients with SCDs want to improve health and avoid unnecessary readmissions.
Care coordination is not currently occurring.
Social Worker is equivalent of Case Manager and perform the same functions.
Schedulers will be available to assist with scheduling follow-up appointments.
Nurses do not provide appropriate/effective training.
Nursing staff do not understand SCD disease management.
Number of patients with SCD won’t change drastically.

Outcomes goal: >/= 20% reduction in 30-day hospital readmission rate of patients with SCD within 3-month timeframe.
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Appendix N: Barriers Action Plan
Barriers

Needs

Healthcare providers and IDT knowledge
deficit regarding SCD

Staff education and awareness regarding
SCD management.

Pathway Adherence

Provider education on the integrated,
electronic SCD care management
pathway.
Provider and staff education on providing
culturally sensitive, nonjudgmental care.

Team Judgment

Patient Lack of Trust

Trust building assessments with patients
and providers.

Staff Resources

Nurses to complete the patient education.
Case Management Staff to schedule the
post-discharge follow-up appointment prior
to discharge and conduct the postdischarge phone calls. Community Health
Worker (CHW) will conduct the home
visits.
Team education on time management of
interventions.
Team education on prioritization of
interventions.
Leadership expectations, oversight, and
accountability.

Time Management
Competing Priorities
Inconsistency and. lack of commitment

IT Support

Distribution of list of patients with SCD.
Distribution of report with intervention
compliance.

Frequency

Facilitator

One time—Pre-implementation training to
medical staff (ED Providers and
Hospitalists), nursing staff, and case
management and social work staff.
One time—Pre-implementation training to
medical staff (ED Providers and
Hospitalists).
One-time—Pre-implementation training to
medical staff (ED Providers and
Hospitalists).

Nurse Education Specialist

Completion of Cultural Mistrust Inventory
(CMI), Trust in Provider Scale (TPS),
Black Racial Identity Attitude Scale
(BRIAS), and/or the Group Based Medical
Mistrust Scale (GBMMS)
Daily education with each patient during
the inpatient stay. One-time scheduling of
follow-up appointment prior to discharge.
Weekly post-discharge follow-up phone
calls.
Two post-discharge home visits.

Nurse Education Specialist

Weekly reinforcement and education.

Director, Case Management and Social
Work.
Director, Case Management and Social
Work
Associate Chief Quality Officer, Case
Management Medical Director, Nursing
leadership, and Case Management
leadership team.
Director of IT.

Weekly reinforcement and education.
Weekly audits and team meetings.

Daily list.
Weekly report.
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Associate Chief Quality Officer

Associate Chief Quality Officer
Sickle Cell Association of Houston

Unit Registered Nurses
Care Coordinators
Community Health Worker

Appendix O: EBP Change Management Model
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Appendix P: ADKAR Management Model
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Appendix Q: Budget
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Appendix Q: Budget continued
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Appendix R: Process Measures Results

SCD-specific education
Threshold >/= 90%
Target >/= 95%

Baseline data: ~51%
Number of encounters with
completed SCD-specific
education

Total number of encounters

Compliance Rate

Post-discharge follow-up
appointments
Threshold >/= 90%
Target >/= 95%

178

178

100%

Baseline data: ~15%
Number of encounters with
post-discharge follow-up
appointment scheduled prior
to discharge

Total number of encounters

Compliance Rate

Reasons appointments not scheduled
Patient Refusal or request for self-schedule
Incomplete appointments
Unplanned discharges
Staff omissions (forgot to schedule)
Late appointments
Total

95

17
14
6
5
4
46

132

178

74%

Appendix S: Outcome Measures Results

Total Inpatient & Emergency Department Visits Principal Diagnosis Sickle Cell
PreImplementation

PostImplementation

Grand Total

134
208
68
410

109
178
52
339

243
386
120
749

PreImplementation

PostImplementation

Variance

Inpatients

208

178

30

30-day readmissions
Readmission Rate

95
46%

64
36%

31

Admit Type
Emergency
Inpatient
Observation
Grand Total

Admit Type

Hospital Stay ALOS
Principal Diagnosis
Sickle Cell

%
Reduction
Overall
Visits
18.7%
14.4%
23.5%
17.3%

-22%

Pre-Implementation

Post-Implementation

Admit Type

Count of
Encounter

Average length
of stay (ALOS)

Count of
Encounter

Average length
of stay (ALOS)

Inpatient
Observation

208
68

7.7
1.0

178
52

6.8
1.0

96

%
Reduction

11.7%
0.0%

